Thiocarbamate inhibitors of alpha-4 integrins

Details Thiocarbamate inhibitors of alpha-4 integrins Thiocarbamate inhibitors of alpha-4 integrins

2007-01-23

2007-01-23

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S255010, C514S423000, C514S307000, C514S278000, C549S439000, C548S531000, C546S015000, C546S309000, C544S173000, C544S176000, C544S389000, C544S383000

Reexamination Certificate

active

11330847

ABSTRACT:
The invention provides novel thiocarbamate alpha-4 inhibitors of the general formula (I) that are resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds wherein substituents L, X, Y, Z, R1–R4, m, n, o and p are as defined herein. Also provided are compositions comprising compounds of formula I and a carrier, diluent or excipient as well as methods of treating a disease or condition mediated by the binding interaction of alpha-4 integrins to its ligands such as inflammatory diseases.

REFERENCES:
patent: 6191171 (2001-02-01), DeLaszlo et al.
patent: 6229011 (2001-05-01), Chen et al.
patent: 6291511 (2001-09-01), Durette et al.
patent: 6329372 (2001-12-01), Head et al.
patent: 6403584 (2002-06-01), de Laszlo et al.
patent: 6410781 (2002-06-01), Konradi et al.
patent: 6469047 (2002-10-01), Jackson et al.
patent: 6521626 (2003-02-01), Archibald et al.
patent: 6534513 (2003-03-01), Porter et al.
patent: 6545160 (2003-04-01), Konradi et al.
patent: 6677339 (2004-01-01), Head et al.
patent: 6689781 (2004-02-01), Konradi et al.
patent: 1154987 (2001-11-01), None
patent: 1161416 (2001-12-01), None
patent: 1270547 (2003-01-01), None
patent: WO 98/46576 (1998-10-01), None
patent: WO 99/10312 (1999-03-01), None
patent: WO 99/36393 (1999-07-01), None
patent: WO 99/37618 (1999-07-01), None
patent: WO 99/50249 (1999-10-01), None
patent: WO 00/37444 (2000-06-01), None
patent: WO 01/21584 (2001-03-01), None
patent: WO 01/68586 (2001-09-01), None
Viney, et al., Mucosal Addressin Cell Adhesion Molecule-1, The Journal of Immunology, 1996, vol. 157: 2488-2497.
Laberge, S. Role of VLA-4 and LFA-1 in Allergen-Induced Airway Hyperresponsiveness and Lung Inflammation in the rat, American J. Respir. Crit. Care Med. 1995, vol. 151: 822-829.
Wikipedia, “Graft-versus-host disease” available at http://en.wikipedia.org/wiki/Graft—versus—host—disease, pp. 1-3 (2006).□□.
Hynes, R.O. Cell, 1992, vol. 69:11-25.
Barbadillo, C. “Anti-integrin immunotherapy in rheumatoid arthritis protective effect of anti-alpha-4 antibody in adjuvant arthritis” Springer Seminars in Immunology (1995) 16: 427-436.

Affiliated with

Also associated with

Rating

Thiocarbamate inhibitors of alpha-4 integrins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiocarbamate inhibitors of alpha-4 integrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiocarbamate inhibitors of alpha-4 integrins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3739804